N. E. Gefen
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- RNA Interference and Gene Delivery 3
- Circular RNAs in diseases 2
- Bacillus and Francisella bacterial research 1
- DNA Repair Mechanisms 1
- Epigenetics and DNA Methylation 1
-
- MicroRNA in disease regulation 4
- Cancer Genomics and Diagnostics 1
- Co-authors
- Shai Izraeli (3 shared papers)Vera Binder (2 shared papers)Arndt Borkhardt (2 shared papers)Danit Lebanony (1 shared paper)Gideon Rechavi (1 shared paper)Avital Dov (1 shared paper)Hila Benjamin (1 shared paper)Dalia Cohen (1 shared paper)
- Journals
- Leukemia (2 papers)PLoS ONE (2 papers)Journal of Clinical Oncology (1 paper)Cancer Biology & Therapy (1 paper)PubMed (2 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
N. E. Gefen
7 papers receiving 700 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 507
- Molecular Biology 488
- Hematology 31
- Oncology 53
- Immunology 42
Countries citing papers authored by N. E. Gefen
This map shows the geographic impact of N. E. Gefen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. E. Gefen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. E. Gefen more than expected).
Fields of papers citing papers by N. E. Gefen
This network shows the impact of papers produced by N. E. Gefen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. E. Gefen. The network helps show where N. E. Gefen may publish in the future.
Co-authors
The 25 scholars most cited alongside N. E. Gefen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 341 | |
| 2 | 2012 | 161 | |
| 3 | 2009 | 97 | |
| 4 | 2011 | 77 | |
| 5 | Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines. | 2006 | 26 |
| 6 | 2010 | 10 | |
| 7 | [Reactivity to and effectiveness of aerogenic vaccination against certain zoonoses]. | 1958 | 3 |
| 8 | EXPERIMENT OF MASS AEROGENIC VACCINATION OF HUMANS AGAINST ANTHRAX | 1968 | 1 |
| 9 | 2014 | 0 |
About N. E. Gefen
N. E. Gefen is a scholar working on Molecular Biology, Cancer Research, Public Health, Environmental and Occupational Health, Genetics and Infectious Diseases, having authored 9 papers that have together received 716 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), RNA Interference and Gene Delivery (3 papers), Circular RNAs in diseases (2 papers), Bacillus and Francisella bacterial research (1 paper), DNA Repair Mechanisms (1 paper), Epigenetics and DNA Methylation (1 paper), Cancer Genomics and Diagnostics (1 paper) and Travel-related health issues (1 paper). The work is most often cited by research in Cancer Research (507 citations), Molecular Biology (488 citations), Hematology (31 citations), Oncology (53 citations) and Immunology (42 citations). N. E. Gefen has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Shai Izraeli, Vera Binder, Arndt Borkhardt, Danit Lebanony, Gideon Rechavi, Avital Dov, Hila Benjamin, Dalia Cohen, Nitzan Rosenfeld and Daisuke Nonaka. Their work appears in journals such as Leukemia, PLoS ONE, Journal of Clinical Oncology, Cancer Biology & Therapy and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.